Shaoqing Ju

Prof. Shaoqing Ju


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2019 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
XLXiwen Li
Xiwen Li
XYXin Yan
Xin Yan
FWFeng Wang
Feng Wang
QYQian Yang
Qian Yang
XLXi Luo
Xi Luo
SJShaoqing Ju
Shaoqing Ju
Mounting evidence has illustrated the vital roles of long non‐coding RNAs (lncRNAs in gastric cancer (GC). Nevertheless, the majority of their roles and mechanisms in GC are still largely unknown. In this study, we investigate the roles of lncRNA SLC25A5‐AS1 on tumourigenesis and explore its potential mechanisms in GC. The results showed that the expressions of SLC25A5‐AS1 in GC were significantly lower than that of adjacent normal tissues, which were significantly associated with tumour size, TNM stage and lymph node metastasis. Moreover, SLC25A5‐AS1 could inhibit GC cell proliferation, induce G1/G1 cell cycle arrest and cell apoptosis in vitro, as well as GC growth in vivo. Dual‐luciferase reporter assay confirmed the direct interaction between SLC25A5‐AS1 and miR‐19a‐3p, rescue experiment showed that co‐transfection miR‐19a‐3p mimics and pcDNA‐SLC25A5‐AS1 could partially restore the ability of GC cell proliferation and the inhibition of cell apoptosis. The mechanism analyses further found that SLC25A5‐AS1 might act as a competing endogenous RNAs (ceRNA), which was involved in the derepression of PTEN expression, a target gene of miR‐19a‐3p, and regulate malignant phenotype via PI3K/AKT signalling pathway in GC. Taken together, this study indicated that SLC25A5‐AS1 was down‐regulated in GC and functioned as a suppressor in the progression of GC. Moreover, it could act as a ceRNA to regulate cellular behaviours via miR‐19a‐3p/PTEN/PI3K/AKT signalling pathway. Thus, SLC25A5‐AS1 might be served as a potential target for cancer therapeutics in GC.

24 September 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
XLXi Luo
Xi Luo
GWGui-Hua Wang
Gui-Hua Wang
ZBZhao-Lian Bian
Zhao-Lian Bian
XLXi-Wen Li
Xi-Wen Li
BZBing-Ying Zhu
Bing-Ying Zhu
SJShaoqing Ju
Shaoqing Ju
Early evidence indicates that the long non-coding RNA CCAL plays a critical role in cancer progression and metastasis. However, the overall biological role and clinical significance of CCAL in gastric tumourigenesis and progression remain largely unknown. We observed that CCAL was upregulated in gastric cancer tissues and was associated with the tumour-node-metastasis stage. Functional experiments showed that CCAL promoted gastric cancer cell proliferation and metastasis in vitro and in vivo. Luciferase reporter assay indicated that CCAL directly bind to miR-149. Moreover, knockdown of CCAL significantly reduced the expression of FOXM1, a direct target of miR-149. We also showed that FOXM1 suppression by miR-149 could be partially rescued by CCAL overexpression. In addition, we identified a negative correlation between the mRNA expression of CCAL and miR-149 in gastric cancer tissues. Furthermore, we observed a negative correlation between the expression of miR-149 and FOXM1 and a positive correlation between CCAL and FOXM1 levels. These results demonstrated that the CCAL/miR-149/FOXM1 axis functions as a key regulator in gastric cancer metastasis and CCAL potentially represents a biomarker for diagnosis and potential target for therapy in the future.

1 January 2020 in Pathology - Research and Practice
Verified
Journal Article
Closed access
WLWenwen Liu
Wenwen Liu
YLYi Li
Yi Li
YZYan Zhang
Yan Zhang
XSXianjuan Shen
Xianjuan Shen
ZSZhangyao Su
Zhangyao Su
SJShaoqing Ju
Shaoqing Ju

1 September 2020 in Journal of Chromatography B
Verified
Journal Article
Closed access
AWAnqi Wu
Anqi Wu
HJHuoyan Ji
Huoyan Ji
YLYi Li
Yi Li
RLRuoyu Liu
Ruoyu Liu
ZHZeyang Hu
Zeyang Hu
FWFeng Wang
Feng Wang